Wolfgang Wick
Impact in
- Genetics top 0.01%
- Glioma Diagnosis and Treatment
- Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism
Papers in
- Genetics 432
- Glioma Diagnosis and Treatment 422
-
- Cancer, Hypoxia, and Metabolism 33
- Co-authors
- Michael Weller (181 shared papers)Michael Platten (122 shared papers)Roger Stupp (35 shared papers)Andreas von Deimling (75 shared papers)Martin Bendszus (146 shared papers)Guido Reifenberger (31 shared papers)Martin J. van den Bent (52 shared papers)Timothy Francis Cloughesy (24 shared papers)
- Journals
- Neuro-Oncology (136 papers)Acta Neuropathologica (50 papers)Journal of Neuro-Oncology (24 papers)Neuro-Oncology Advances (21 papers)Journal of Clinical Oncology (18 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Wolfgang Wick
722 papers receiving 74.7k citations
Wolfgang Wick's Hit Papers
Peers
Comparison fields: 5 of 217
- Genetics 37.6k
- Cancer Research 11.3k
- Biological Psychiatry 1.9k
- Oncology 10.5k
- Radiology, Nuclear Medicine and Imaging 8.8k
Countries citing papers authored by Wolfgang Wick
This map shows the geographic impact of Wolfgang Wick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Wick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Wick more than expected).
Fields of papers citing papers by Wolfgang Wick
This network shows the impact of papers produced by Wolfgang Wick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Wick. The network helps show where Wolfgang Wick may publish in the future.
Co-authors
The 25 scholars most cited alongside Wolfgang Wick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 753 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group Hit paper breakdown → | 2010 | 3183 |
| 2 | DNA methylation-based classification of central nervous system tumours Hit paper breakdown → | 2018 | 2183 |
| 3 | Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma Hit paper breakdown → | 2014 | 2092 |
| 4 | An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor Hit paper breakdown → | 2011 | 1605 |
| 5 | Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma Hit paper breakdown → | 2012 | 1513 |
| 6 | EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood Hit paper breakdown → | 2020 | 1327 |
| 7 | Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas Hit paper breakdown → | 2009 | 991 |
| 8 | Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial Hit paper breakdown → | 2017 | 930 |
| 9 | Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial Hit paper breakdown → | 2012 | 908 |
| 10 | Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions Hit paper breakdown → | 2020 | 877 |
| 11 | Brain tumour cells interconnect to a functional and resistant network Hit paper breakdown → | 2015 | 873 |
| 12 | European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas Hit paper breakdown → | 2017 | 873 |
| 13 | Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial Hit paper breakdown → | 2014 | 872 |
| 14 | Glioma Hit paper breakdown → | 2015 | 871 |
| 15 | Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma Hit paper breakdown → | 2017 | 869 |
| 16 | Glutamatergic synaptic input to glioma cells drives brain tumour progression Hit paper breakdown → | 2019 | 829 |
| 17 | Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2022 | 807 |
| 18 | How to use and assess qualitative research methods Hit paper breakdown → | 2020 | 784 |
| 19 | Actively personalized vaccination trial for newly diagnosed glioblastoma Hit paper breakdown → | 2018 | 764 |
| 20 | Lomustine and Bevacizumab in Progressive Glioblastoma Hit paper breakdown → | 2017 | 742 |
About Wolfgang Wick
Wolfgang Wick is a scholar working on Genetics, Cancer Research, Neurology, Pulmonary and Respiratory Medicine and Oncology, having authored 753 papers that have together received 76.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (422 papers), Brain Metastases and Treatment (72 papers), Meningioma and schwannoma management (48 papers), Epigenetics and DNA Methylation (40 papers), Radiomics and Machine Learning in Medical Imaging (36 papers), Cancer, Hypoxia, and Metabolism (33 papers), Cancer Immunotherapy and Biomarkers (29 papers) and Histone Deacetylase Inhibitors Research (27 papers). The work is most often cited by research in Genetics (37.6k citations), Cancer Research (11.3k citations), Biological Psychiatry (1.9k citations), Oncology (10.5k citations) and Radiology, Nuclear Medicine and Imaging (8.8k citations). Wolfgang Wick has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Michael Weller, Michael Platten, Roger Stupp, Andreas von Deimling, Martin Bendszus, Guido Reifenberger, Martin J. van den Bent, Timothy Francis Cloughesy, Philipp Kickingereder and Felix Sahm. Their work appears in journals such as Neuro-Oncology, Acta Neuropathologica, Journal of Neuro-Oncology, Neuro-Oncology Advances and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.